[Federal Register Volume 72, Number 13 (Monday, January 22, 2007)]
[Notices]
[Pages 2700-2701]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 07-244]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Clinical Center; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice

[[Page 2701]]

is hereby given of a meeting of the NIH Advisory Board for Clinical 
Research.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended 
to discuss personnel matters, the disclosure of which would constitute 
a clearly unwarranted invasion of personal privacy.

    Name of Committee: NIH Advisory Board for Clinical Research.
    Date: January 29, 2007.
    Open: 10 a.m. to 1:15 p.m.
    Agenda: To review the Clinical Center's operating plan and 
provide updates on selected organizational initiatives.
    Place: National Institutes of Health, Building 10, 10 Center 
Drive, CRC Medical Board, Room 4-2551, Bethesda, MD 20892.
    Closed: 1:15 p.m. to 2 p.m.
    Agenda: To review personnel matters.
    Place: National Institutes of Health, Building 10, 10 Center 
Drive, CRC Medical Board, Room 4-2551, Bethesda, MD 20892.
    Contact Person: Maureen E Gormley, Executive Secretary, Mark O. 
Hatfield Clinical Research Center, National Institutes of Health, 
Building 10, Room 6-2551, Bethesda, MD 20892, 301/496-2897.
    This notice is being published less than 15 days prior to the 
meeting due to the urgent need to meet timing limitations imposed by 
the intramural research review cycle.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.

    Dated: January 11, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-244 Filed 1-19-07; 8:45 am]
BILLING CODE 4140-071-M